Paion AG Performance
| PAIOFDelisted Stock | USD 0.02 0.00 0.00% |
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Paion AG are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Paion AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Paion AG is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 19.7 M | |
| Total Cashflows From Investing Activities | -19.2 M |
Paion |
Paion AG Relative Risk vs. Return Landscape
If you would invest 2.00 in Paion AG on November 10, 2025 and sell it today you would earn a total of 0.00 from holding Paion AG or generate 0.0% return on investment over 90 days. Paion AG is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Paion, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Paion AG Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Paion AG for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Paion AG can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Paion AG is not yet fully synchronised with the market data | |
| Paion AG has some characteristics of a very speculative penny stock | |
| Paion AG has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 7.13 M. Net Loss for the year was (21.79 M) with profit before overhead, payroll, taxes, and interest of 4.05 M. | |
| Paion AG has accumulated about 17.69 M in cash with (21.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.25, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Paion AG Fundamentals Growth
Paion Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Paion AG, and Paion AG fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Paion Pink Sheet performance.
| Return On Equity | -0.0965 | |||
| Return On Asset | -0.033 | |||
| Profit Margin | (0.09) % | |||
| Operating Margin | (0.11) % | |||
| Current Valuation | 67.38 M | |||
| Shares Outstanding | 71.34 M | |||
| Price To Earning | 20.83 X | |||
| Price To Book | 3.01 X | |||
| Price To Sales | 2.22 X | |||
| Revenue | 7.13 M | |||
| EBITDA | (18.82 M) | |||
| Cash And Equivalents | 17.69 M | |||
| Cash Per Share | 0.25 X | |||
| Total Debt | 18.2 M | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | 0.24 X | |||
| Cash Flow From Operations | (21.18 M) | |||
| Earnings Per Share | (0.33) X | |||
| Total Asset | 36.78 M | |||
About Paion AG Performance
By analyzing Paion AG's fundamental ratios, stakeholders can gain valuable insights into Paion AG's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Paion AG has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Paion AG has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and critical care services worldwide. Paion AG was founded in 2000 and is based in Aachen, Germany. Paion Ag operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 64 people.Things to note about Paion AG performance evaluation
Checking the ongoing alerts about Paion AG for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Paion AG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Paion AG is not yet fully synchronised with the market data | |
| Paion AG has some characteristics of a very speculative penny stock | |
| Paion AG has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 7.13 M. Net Loss for the year was (21.79 M) with profit before overhead, payroll, taxes, and interest of 4.05 M. | |
| Paion AG has accumulated about 17.69 M in cash with (21.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.25, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Paion AG's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Paion AG's stock is overvalued or undervalued compared to its peers.
- Examining Paion AG's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Paion AG's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Paion AG's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Paion AG's pink sheet. These opinions can provide insight into Paion AG's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Paion Pink Sheet
If you are still planning to invest in Paion AG check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Paion AG's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |